If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
310.60    5.80 (1.90%)
Bid:
310.20
Ask:
310.60
Spread: 0.40 (0.129%)
Market Cap: £1.08b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Director/PDMR Shareholding

9 Mar 2017 10:13

RNS Number : 9920Y
Breedon Group PLC
09 March 2017
 

 

9 March 2017

 

 

BREEDON GROUP plc

("Breedon" or the "Company")

 

PDMR Dealings

 

Breedon announces that, on 9 March 2017, Mr Alan Mackenzie, Chief Executive of Breedon Northern and a PDMR, has today sold 17,500 Ordinary Shares at a price of 79.3p.

 

As at today there are 1,411,075,324 Ordinary Shares in issue. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.

 

Enquiries:

Breedon Group plc www.breedongroup.com

 

Pat Ward, Group Chief Executive 01332 694010

Stephen Jacobs, Head of Communications 07831 764592

 

 

Cenkos Securities plc (NOMAD and joint broker)

Max Hartley 020 7397 8900

 

Peel Hunt (Joint Broker)

Justin Jones / Mike Bell 020 7418 8900

 

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Alan Mackenzie 

2

 

Reason for the notification

 

a)

 

Position/status

Chief Executive, Breedon Northern (PDMR)

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Breedon Group plc

b)

 

LEI

213800ZQKCIVCPN9H229

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 Ordinary Shares of no par value

 

ISIN: JE00B2419D89

b)

 

Nature of the transaction

Sale of ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

 

 79.3p per share

 

 17,500

 

d)

 

Aggregated information

 - Aggregated volume

 - Price

17,500

79.3p per share

 

e)

 

Date of the transaction

9 March 2017

f)

 

Place of the transaction

London Stock Exchange (AIM)

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSFFSUFWSEFD
Date   Source Headline
17th Jul 202512:37 pmRNS-RNotice of live interactive presentation on Engage
30th Jun 20257:00 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSBlock Listing Six Monthly Return
27th Jun 20254:10 pmRNSHolding(s) in Company
24th Jun 20251:00 pmRNSNotice of Interim Results
16th Jun 20254:42 pmRNSDirector/PDMR Shareholding
30th May 20259:41 amRNSTotal Voting Rights
6th May 20252:15 pmRNSHolding(s) in Company
2nd May 20253:34 pmRNSDirector/PDMR Shareholding
30th Apr 202512:46 pmRNSTotal Voting Rights
29th Apr 20254:55 pmRNSResult of AGM
29th Apr 20257:00 amRNSAGM Trading Update
17th Apr 20253:24 pmRNSHolding(s) in Company
15th Apr 20251:27 pmRNSDirector/PDMR Shareholding
15th Apr 20259:25 amRNSHolding(s) in Company
15th Apr 20259:23 amRNSHolding(s) in Company
9th Apr 20253:31 pmRNSHolding(s) in Company
8th Apr 20255:16 pmRNSDirector/PDMR Shareholding
8th Apr 20255:15 pmRNSDirector/PDMR Shareholding
31st Mar 20253:23 pmRNSTotal Voting Rights
26th Mar 20252:34 pmRNSHolding(s) in Company
17th Mar 202510:10 amRNS2024 Annual Report and Notice of AGM
12th Mar 20253:35 pmRNSApplication for Admission of Consideration Shares
7th Mar 20257:00 amRNS-RLive presentation via Investor Meet Company
6th Mar 202512:00 pmRNSCompletion of Acquisition
5th Mar 20257:01 amRNSAcquisition
5th Mar 20257:00 amRNSFinal Results
28th Feb 20251:56 pmRNSTotal Voting Rights
4th Feb 20259:25 amRNSNotice of Results
31st Jan 20257:00 amRNSTotal Voting Rights
31st Dec 20247:00 amRNSBlock listing six monthly return
31st Dec 20247:00 amRNSTotal Voting Rights
2nd Dec 20244:40 pmRNSDirector/PDMR Shareholding
29th Nov 20249:15 amRNSTotal Voting Rights
21st Nov 20247:00 amRNSNovember Trading Statement
12th Nov 20245:06 pmRNSDirector/PDMR Shareholding
31st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 20241:55 pmRNSTotal Voting Rights
30th Aug 20248:49 amRNSTotal Voting Rights
31st Jul 202410:11 amRNSTotal Voting Rights
24th Jul 20247:00 amRNSInterim results 2024
11th Jul 20244:33 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSBlock listing six monthly return
28th Jun 20247:00 amRNSTotal Voting Rights
25th Jun 20242:38 pmRNSNotice of Results
13th Jun 20243:53 pmRNSDirector/PDMR Shareholding
12th Jun 20245:16 pmRNSHolding(s) in Company
12th Jun 20244:31 pmRNSDirector/PDMR Shareholding
11th Jun 20244:28 pmRNSHolding(s) in Company
6th Jun 20242:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.